Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Bon Natural Life Reports Received Initial Purchase Order For Stachyose, Apple Extract-Based Personal Care Products, No Terms Disclosed


Benzinga | Jan 12, 2022 08:35AM EST

Bon Natural Life Reports Received Initial Purchase Order For Stachyose, Apple Extract-Based Personal Care Products, No Terms Disclosed

Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has received an initial purchase order (the "Order") from Chongqing Fudoudou Technology Co., Limited ("FDD"), the wholly owned subsidiary of Chongqing Jingfubao Trading Co., Limited ("JFB"), for FeatherPure Women's Personal Care Gel ("FeatherPure"), to provide female reproductive system care. The Company has begun delivering products to JFB.

FeatherPure is one of the first female personal care products that leverages human micro-bio technologies with BON's proprietary stachyose and apple extract formulation. It is also an all-natural product with no antibiotics, fragrance, harmful chemical additives or harmful side effects. Aiming to achieve a health microbial balance of female reproductive system, FeatherPure also helps adjust the PH value of female reproductive system to a desirable level and has anti-bacterial and anti-inflammatory functions. The next purchase order will be determined and negotiated based on market feedback and demand. The Company expects FeatherPure will bring approximately US$3 million in revenue in the next 2 years. The Company has received full advance payment for the initial order from FDD.

"We are excited to officially kick off the partnership with FDD. This represents a unique opportunity for BON to gain enhanced access to FDD's extensive retail consumer network." Commented Richard (Yongwei) Hu, the Chairman and CEO of Bon Natural Life Limited, "As adoption of women's health awareness continues to rise, we expect women's health expenditure will grow exponentially and FeatherPure will take the lead in the market. At the same time, we are currently in communication with FDD about co-developing other healthcare products in response to the vast market demand. We believe that the partnership with FDD will additional source of revenue growth with an expected revenue increase of US$10 million in 3 years and create more compelling values to our shareholders."






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC